• Explore /
  • Poster
  • / Phase II studies of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced squamous (sq) or nonsquamous (non-sq) non-small cell lung cancer (NSCLC).

Phase II studies of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced squamous (sq) or nonsquamous (non-sq) non-small cell lung cancer (NSCLC).

Abstract Poster

Authors

null

Makoto Nishio

Japanese Foundation for Cancer Research, Tokyo, Japan

Makoto Nishio , Toyoaki Hida , Kazuhiko Nakagawa , Hiroshi Sakai , Naoyuki Nogami , Shinji Atagi , Toshiaki Takahashi , Hiroshi Nokihara , Hideo Saka , Mitsuhiro Takenoyama , Shiro Fujita , Hiroshi Tanaka , Koji Takeda , Miyako Satouchi , Hiroshi Isobe , Makoto Maemondo , Koichi Goto , Tomonori Hirashima , Koichi Minato , Tomohide Tamura

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

132072 and 132073

Citation

J Clin Oncol 33, 2015 (suppl; abstr 8027)

DOI

10.1200/jco.2015.33.15_suppl.8027

Abstract #

8027

Poster Bd #

349

Abstract Disclosures

Similar Posters

First Author: Alberto Fusi

First Author: Bridget Keenan

First Author: Dingzhi Huang

First Author: Saveri Bhattacharya